Professor Winter undertook his undergraduate medical training at the University of Bristol during which time he spent a further year gaining a BSc in Anatomy. He qualified as a doctor in 1997.
He completed his initial surgical training in the South West of England and the Oxford region, gaining a broad surgical experience. During this time he has also taught Anatomy to the medical students at the University of Oxford. He then completed his higher surgical training in Ear Nose and Throat Surgery on the Oxford training programme.
MD MB chB BSc FRCS (ORL-HNS)
- Consultant Ear Nose and Throat, Head and Neck Surgeon
- Clinical Lead for Head and Neck Surgery
Stuart Winter is Associate Professor and a Consultant Ear, Nose & Throat (ENT) Surgeon based at the John Radcliffe and Churchill Hospitals.
He has a specialist interest in tumours of the head and neck, both benign and malignant. He is a recognised national expert in the treatment and management of tumours. He is a member of the Oxford Head and Neck Multidisciplinary Team and Clinical Lead for Head and Neck Surgery at Oxford University Hospitals NHS Foundation Trust.
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Nepogodiev D. et al, (2020), The Lancet, 396, 27 - 38
Endoscopic pharyngeal pouch stapling: A retrospective study of 55 patients comparing intubation difficulty and body mass index as factors for success.
Bola S. et al, (2020), Clin Otolaryngol, 45, 135 - 138
Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling.
Qureishi A. et al, (2019), Clin Otolaryngol, 44, 1026 - 1036
Transoral tongue base mucosectomy for the identification of the primary site in the work-up of cancers of unknown origin: Systematic review and meta-analysis.
Farooq S. et al, (2019), Oral Oncol, 91, 97 - 106
Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer.
Casselden E. et al, (2019), Eur Arch Otorhinolaryngol, 276, 243 - 247